Contact us

Agenda

Reception & networking
(breakfast buffet open)

Invitations only

9:30
Reception & networking
(breakfast buffet open)
Marek Kiecana & Ingrid Klingmann
Welcome and Opening Remarks

Marek Kiecana & Ingrid Klingmann

CEO, Biokinetica
10:00
Welcome and Opening Remarks
Michal Zmyslowski
How to remain competitive – conclusions from the report "Industry Clinical Trials in Poland - Progress Review Through 2024"

Michał Zmysłowski, MSc, EMBA

Speaker
10:05
How to remain competitive – conclusions from the report "Industry Clinical Trials in Poland - Progress Review Through 2024"
Ingrid-Klingmann
"European countries’ strategies to increase their attractivity for clinical trials"

Ingrid Klingmann, M.D., PH.D.

Speaker
10:20
"European countries’ strategies to increase their attractivity for clinical trials"
Ronald Koening
“The Netherlands – dedicated early-phase ethics committee and accelerated regulatory review strategies”

Ronald Koning, M.D., NP

Speaker
10:40
“The Netherlands – dedicated early-phase ethics committee and accelerated regulatory review strategies”
Olga Zielinska
Legal perspective – possibilities within the existing CTR framework.

Olga Zielińska, Lawyer

Speaker
11:00
Legal perspective – possibilities within the existing CTR framework.

Coffee break

11:10
Ingrid-Klingmann
Discussions & next steps

Ingrid Klingmann, M.D., PH.D.

Moderator
11:30
Discussions & next steps
Agnieszka Kulesza
Closing Remarks

Agnieszka Kulesza

COO, Biokinetica
13:00
Closing Remarks
Networking
13:05
Networking
End of the event
13:30
End of the event

Contact us

The Netherlands flag

Services

Expertise

Clinical Research Unit (CRU)

Biokinetica

Sponsor a study
2020 – 2025 Biokinetica. All right reserved. Privacy policy

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.

I accept
Privacy policy